Gastrointestinal Cancer News

The FDA granted priority review to regorafenib tablets as a second-line systemic treatment for patients with hepatocellular carcinoma, according to the drug’s manufacturer.

Clinical Genomics has launched a blood-based test for monitoring colorectal cancer recurrence called Colvera, the company announced.

In 2015, hepatocellular carcinoma was the most common indication for liver transplantation in the U.S., yet the likelihood of receiving a transplantation decreased the most among waitlist registrants with this cancer, according to recent study data.

Although the incidence of hepatocellular carcinoma continued to rise, researchers discovered the rate of increase slowed between 2010 and 2012, except among high risk subgroups in certain geographic regions.

David H. Ilson, MD, PhD, is a medical oncologist at Memorial Sloan Kettering Cancer Center and a HemOnc Today Editorial Board member.

The U.S. Multi-Society Task Force on Colorectal Cancer has released new guideline recommendations on the use of fecal immunochemical tests for colorectal cancer screening, which are published simultaneously in Gastrointestinal Endoscopy, Gastroenterology, and the American Journal of Gastroenterology.

Regular use of aspirin may lower the risk for pancreatic cancer by as much as 46%, according to a population-based, case-control study conducted in China.

Ninety-five percent of patients with advanced cancer have an insufficient understanding of their prognosis and are ill-equipped to make informed end-of-life care decisions, according to results of a prospective, multi-institutional cohort study published in Journal of Clinical Oncology.

Researchers identified five bowel traits common in patients with non-metastatic colorectal cancer, and say such patients should be referred immediately to a specialist for further examination, according to research published in the British Journal of General Practice.

Circulating tumor DNA isolated from blood samples in patients with pancreatic adenocarcinoma independently predicted survival, according to prospective study results.